Search

everythinglearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

A new compound may treat benign prostatic hyperplasia better than finasteride.

JAK inhibitors show promise for treating skin diseases effectively and safely.

Finasteride increases CD8+ T cells in BPH tissues.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.